Alexandros Pantalis
21 Jan 2026Europes Newest Unicorn Joins, Eleven Labs Eyes $11B, Sequoia Looks To Anthropic, $1M X Article Payou
Alexandros Pantalis Introduces Fagos
Fagos co-founder and CEO Alexandros Pantalis joins and introduces the company he founded five years ago with his co-founder Adele (CTO), stating the mission "to end bacterial disease." He frames bacterial disease as the second leading cause of death for humans and a top killer of animals; the interview continues beyond this part.
21 Jan 2026ElevenLabs $11B, Sequoia Eyes Anthropic, $1M Article Payout, King Klinger
Phagos CEO Alexandros Pantalis: Ending Bacterial Disease with Bacteriophages
Alexandros Pantalis, co-founder and CEO of Phagos, explains that bacterial disease is the second leading cause of human death and that antibiotics are failing, with resistance rising 10-15% per year and one in three antibiotics already failing in animal health. He describes using bacteriophages — bacteria's natural predators — matched to infections with microbiology and AI, the company's €25M Series A, and its first-in-the-world European authorization to sell personalized phage therapies as mainstream veterinary pharmaceuticals. He notes roughly 150 phage companies exist globally with about 20 in veterinary, and Phagos differentiates by building per-farm personalized 'cocktails' instead of broad-spectrum solutions that repeat antibiotics' resistance mistakes.
Phagos Roadmap: One Million Animals Healed and the Path to Humans
Alexandros lays out Phagos's three-phase roadmap — eliminating bacteria in vitro, healing a living organism in vivo, then succeeding in messy commercial farm settings — and reports over one million animals healed in France, starting with chickens and pigs with cows next. On the path to human health, he says the goal is billions of animals treated, pointing to a $2 trillion animal production market where about 20% is lost to disease each year. He also explains how AI was integrated into phage matching from day one and gives a shout-out to the multidisciplinary team before wrapping up.